The purpose of IPRP is to create an environment for its regulatory members and observers to exchange information on issues of mutual interest, enable cooperation and promote convergence of regulatory approaches for pharmaceutical medicinal products for human use.
The International Pharmaceutical Regulators Programme (IPRP) was created as a result of the consolidation of the International Pharmaceutical Regulators Forum (IPRF) and the International Generic Drug Regulators Programme (IGDRP) and was officially launched on January 1st, 2018.
The global context of medicines regulation is becoming increasingly complex, requiring a constant evolution in regulatory sciences to adapt to the pace of change. The purpose of IPRP is to create an environment for its regulatory members and observers to exchange information on issues of mutual interest, enable cooperation and promote convergence of regulatory approaches for pharmaceutical medicinal products for human use. Through its Management Committee and various working groups, IPRP facilitates discussions on global regulatory issues and on emerging technologies. IPRP also provides a venue to support the implementation of ICH guidelines and other standards, and for inter-agency information sharing and collaboration.
While maintaining its focus as a forum for regulators to share best practices and experiences, IPRP is also committed to engage with its external stakeholders where needed. The IPRP Stakeholder Engagement Plan identifies target IPRP external stakeholders, lays down the engagement objectives, specifies IPRP’s principles of engagement and outlines proposed activities of outreach and involvement. It is available for download.